ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,022.21
      -0.58%
      US Tech 100
      17,094.40
      0.36%
      Dow Jones
      37,753.31
      0.00%
      Brent Oil
      86.425
      -0.64%
      Bitcoin
      62,708.42
      2.33%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Agenus Inc (AGEN)

      7. Agenus Inc (AGEN) News

      AGEN

      Agenus (AGEN)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AGEN
      DateTimeSourceHeadlineSymbolCompany
      12:00PMiHub NewswireFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
      04/12/20247:30AMBusiness WireAgenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal CancerNASDAQ:AGENAgenus Inc
      04/05/20244:30PMBusiness WireAgenus Announces Reverse Stock Split of Common StockNASDAQ:AGENAgenus Inc
      03/14/20247:30AMBusiness WireAgenus Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:AGENAgenus Inc
      03/06/20247:30AMBusiness WireAgenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024NASDAQ:AGENAgenus Inc
      03/05/20244:30PMBusiness WireAgenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGENAgenus Inc
      02/29/20244:50PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AGENAgenus Inc
      02/29/20247:30AMBusiness WireAgenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial ReportNASDAQ:AGENAgenus Inc
      02/26/20244:24PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AGENAgenus Inc
      02/26/20247:30AMBusiness WireAgenus to Participate in Leerink Partners Global Biopharma ConferenceNASDAQ:AGENAgenus Inc
      02/15/20248:02AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AGENAgenus Inc
      02/15/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGENAgenus Inc
      02/15/20247:02AMPR Newswire (US)Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular DesignNASDAQ:AGENAgenus Inc
      02/14/20248:33AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGENAgenus Inc
      02/12/20247:00AMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
      02/12/20247:00AMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
      02/09/20245:11PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGENAgenus Inc
      01/31/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGENAgenus Inc
      01/31/20247:30AMBusiness WireAgenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:AGENAgenus Inc
      01/22/20249:59AMBusiness WireBotensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer PopulationNASDAQ:AGENAgenus Inc
      01/22/20247:30AMBusiness WireBotensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer PopulationNASDAQ:AGENAgenus Inc
      01/05/20244:30PMBusiness WireAgenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGENAgenus Inc
      01/04/20247:30AMBusiness WireAgenus to Participate in B. Riley Healthcare ConferenceNASDAQ:AGENAgenus Inc
      01/04/20246:06AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
      01/04/20246:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
      01/04/20246:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
      12/20/20237:30AMBusiness WireBotensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024NASDAQ:AGENAgenus Inc
      12/11/20237:30AMBusiness WireAgenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific ProgramNASDAQ:AGENAgenus Inc
      12/08/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGENAgenus Inc
      11/17/20234:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGENAgenus Inc
       Showing the most relevant articles for your search:NASDAQ:AGEN